From: Cannabinoid treatment for autism: a proof-of-concept randomized trial
 | Median (range) [n] | Pairwise P | ||||
---|---|---|---|---|---|---|
Assessment | Whole-plant extract | Pure cannabinoids | Placebo | Whole-plant versus placebo | Pure C. versus placebo | Whole-plant versus pure C |
HSQ-ASD |  − 1.1 (− 3.8 to 1.6) [40] |  − 0.7 (− 4.4 to 3.8) [42] |  − 0.5 (− 3.7 to 2.5) [39] | 0.575 | 0.915 | 0.508 |
SRS-2 |  − 14.9 (− 45 to 15) [34] |  − 8.2 (− 69 to 45) [28] |  − 3.6 (− 63 to 35) [36] | 0.009 | 0.801 | 0.202 |
APSI |  − 5.4 (− 39 to 13) [38] |  − 4.9 (− 19 to 22) [42] |  − 1.5 (− 26 to 20) [42] | 0.502 | 0.513 | 0.991 |